The results showed that the relative gene expression of EBI3 in CD19+ B cells of patients with active sarcoidosis was significantly higher as compared to patients with stable sarcoidosis (P=0.032) and the control group (Figure 5A, P = 0.032). This evidence concerns the gene CD19 and sarcoidosis.